Sanofi
VS
Triveni Bio

Biotech comparison — funding, valuation, and investors, sourced from Value Add Pulse coverage.

S
Sanofi

Sanofi is a global biopharmaceutical company developing and manufacturing medicines and vaccines across specialty care, immunology, oncology, and rare diseases.

2 Pulse stories
TB
Triveni Bio

Triveni Bio develops genetics-informed antibody and bispecific therapeutics for immunological and inflammatory diseases.

2 Pulse stories
Total Raised
$272M
SanofiTriveni Bio
Last ValuationNot disclosed
Biotech
Sector
Biotech
1973
Founded
2023
Paris, France
HQ
Waltham, Massachusetts
Public (SNY)
Status
Private
Sanofi investors
No investors on record.
Triveni Bio investors
Atlas VentureCormorant Asset ManagementAscenta CapitalJanus Henderson InvestorsDeep Track CapitalOrbiMedViking Global InvestorsFidelity Management & Research

Data from Value Add Pulse coverage and company research — see the full threads for Sanofi and Triveni Bio.